Highlighted for Making Cannabis Meds More Affordable to
Patients
MIAMI, FL -- April 10, 2017 -- InvestorsHub NewsWire -- Novus
Acquisition and Development, Corp. (OTC Markets:
NDEV), through its wholly owned subsidiary WCIG Insurance
Services, Inc., is a diversified insurance entity in health,
liability, annuity and accident, and, the nations first
carrier/aggregator offering a cannabis health plan, is pleased to
announce that it has been featured on the cover of CannaInvestor
Magazine March/April 2017 edition.
NOVUS
Health |Life | Liability
We are pleased to announce to cannabis investors, analysts,
entrepreneurs, and financial media that the new digital issue of
CANNAINVESTOR Magazine for March / April 2017 has been
published and is now available
for viewing FREE online at http://bit.ly/2oXuPKb. This in-depth exclusive
interview will demonstrate how Novus is an influencer in the
cannabis sector.
The feature article spans over 25 pages and covers such topics
as:
- MMJ competitive assessment
- Novus provider network
- Uniqueness of being a Novus provider
- Novus price plans and insurance model
- Novus digital marketing platform
- Regulatory compliance
About Novus
Novus Acquisition & Development Corp. (NDEV),
through its subsidiary WCIG Insurance, provides health insurance
and related insurance solutions within the wellness and medical
marijuana industries in states where legal programs exist. Novus
has developed its infrastructure within many lines of the insurance
business such as, health, property & casualty, life, accident
and fixed annuities.
Novus medical cannabis benefits package will work as outside
developers and will not cultivate, handle, transport grow, extract,
dispense, put up for sale, put on the market, vend, deliver,
supply, circulate, or trade cannabis or any substances that violate
the United States law or the Controlled Substances Act, nor does it
intend to do so in the future and will continue to follow state and
federal laws. The statements made about specific products have not
been evaluated by the United States Food and Drug Administration
(FDA) and are not intended to diagnose, treat, cure or prevent
disease. All information provided on these press releases or any
information contained on or in any product label or packaging is
for informational purposes only and is not intended as a substitute
for advice from your physician or other health care professional.
Once a push notification is competed the transaction is solely
between the state-licensed dispensary and the registered
patient.
The state laws are in conflict with the federal Controlled
Substances Act. The current administration has effectively stated
that it is not an efficient use of resources to direct federal law
enforcement agencies to prosecute those lawfully abiding by state
designated laws, allowing the use and distribution of medical
marijuana. However, there is no guarantee that the current
administration, nor any future administration, will not change this
policy and decide to enforce the federal laws strongly. Any such
change in the federal government's enforcement of current federal
laws could cause significant financial changes to Novus Medical
Group. While we do not intend to harvest, distribute or sell
cannabis or cannabis related products, we may be harmed by a change
in enforcement by federal or state governments.
Forward-Looking Statements
This release includes forward-looking statements, which are
based on certain assumptions and reflects management's current
expectations. These forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results
or events to differ materially from current expectations. Some of
these factors include: general global economic conditions; general
industry and market conditions and growth rates; uncertainty as to
whether our strategies and business plans will yield the expected
benefits; increasing competition; availability and cost of capital;
the ability to identify and develop and achieve commercial success;
the level of expenditures necessary to maintain and improve the
quality of services; changes in the economy; changes in laws and
regulations, includes codes and standards, intellectual property
rights, and tax matters; or other matters not anticipated; our
ability to secure and maintain strategic relationships and
distribution agreements. Novus Medical Group disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise.
Contact Information
Corporate:
Chairman and CEO
Frank Labrozzi
frank@ndev.biz
855-228-7355
Investors:
Hayden IR
hart@haydenir.com
917-658-7878
